BIOZOOM, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2013-06-20: Form 8-K; Period of report 2013-06-20; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2013-06-06: Form 8-K; Period of report 2013-06-05; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events; Details 8.01.
- 2013-05-31: Form 8-K; Period of report 2013-05-31; Description 8.01 Other Events; Details 8.01.
- 2013-05-29: Form 8-K; Period of report 2013-05-28; Description 8.01 Other Events; Details 8.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2013-06-20 | 8-K | 2013-06-20 | 1.01 Entry into a Material Definitive Agreement | 1.01 On June 14, 2013, the registrant’s wholly owned subsidiary, Biozoom Technologies, Inc. exercised its option, pursuant to its February 28, 2013 joint venture agreement with Opsolution GmbH, a German company, to acquire 19.9% of Opsolution GmbH for $9,950. | form8k.htm |
| 2013-06-06 | 8-K | 2013-06-05 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 8.01 On May 31, 2013, the registrant Biozoom, Inc.'s wholly owned subsidiary, Biozoom Technologies, Inc. (the “Company”), entered into a Scientific Advisory Board Consulting Agreement with Prof. | form8k.htm |
| 2013-05-31 | 8-K | 2013-05-31 | 8.01 Other Events | 8.01 On or about February 25, 2013, Dr. Wolfgang Köcher, Chief Technology Officer and Director of the registrant, received a letter (the “Charité Letter”) from the Charité - Universitätsmedizin Berlin (“Charité”), Center of Experimental and Applied Cutaneous Physiology, regarding the efficacy, past use by the Charité, and potential use of the registrant’s handheld mobile spectroscopic scanner technology. | form8k.htm |
| 2013-05-29 | 8-K | 2013-05-28 | 8.01 Other Events | 8.01 On April 30, 2013, the registrant Biozoom, Inc.’s wholly owned subsidiary, Biozoom Technologies, Inc., (the “Company”) entered into a Scientific Advisory Board Consulting Agreement with Prof. | form8k.htm |
| 2013-05-24 | 8-K | 2013-05-23 | 1.01 Entry into a Material Definitive Agreement | 1.01 On May 21, 2013, Biozoom, Inc. (the “Company”) entered into a consulting agreement with Tefa Dexter, its Secretary. | form8k.htm |
| 2013-05-21 | 8-K | 2013-05-21 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 On March 15, 2013, the registrant, Biozoom, Inc., through its wholly owned operational subsidiary, Biozoom Technologies, Inc., (the “Company”) entered into an employment agreement with Hardy Hoheisel, the registrant’s Chief Executive Officer and member of the Board of Directors. 8.01 As of May 21, 2013, the registrant has relocated its headquarters and principal executive offices to Wilhelmshoeher Allee 273A, Kassel, Germany, 34131. | form8k.htm |
| 2013-04-02 | 8-K | 2013-03-11 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 On March 11, 2013, Biozoom, Inc. f/k/a Entertainment Art, Inc. (the “Registrant”) filed Articles of Merger with the Nevada Secretary of State pursuant to the Nevada Revised Statutes (92A.180) to change its name from “Entertainment Art, Inc.” to “Biozoom, Inc.” (the “Name Change”). | form8k.htm |
| 2013-03-12 | 8-K | 2013-02-28 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.06 Change in Shell Company Status | 1.01 Entry into a Material Definitive Agreement. 2.01 The disclosure in Item 1.01 of this Report regarding the Acquisition is incorporated herein by reference in its entirety. 3.02 The information contained in Item 1.01 above is incorporated herein by reference in response to this Item 3.02. 5.01 See disclosure set forth under Item 2.01 of this Report, which disclosure is incorporated herein by reference. 5.02 Departure of Directors or Principal officers; Election of Directors; Appointment of Principal Officers. 5.06 See disclosure set forth under Item 2.01 of this Report, which disclosure is incorporated herein by reference. | form8k.htm |
| 2013-02-06 | 8-K | 2013-01-21 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On January 21, 2013, Entertainment Art, Inc. (the “Company”) received a resignation notice from Sarah Deutsch as Secretary of the Company. | form8k.htm |
| 2012-10-25 | 8-K | 2012-10-19 | 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.01 On October 19, 2012, a change in control of Entertainment Art, Inc. (the "Company") occurred when Medford Financial Ltd. (“Medford”) sold all of its 39,600,000 common shares in a private share purchase transaction to Le Mond Capital (“Le Mond”). 5.02 On October 19, 2012, the Company received a resignation notice from Jeff Lamson from all of his positions with the Company, including President, CEO, Principal Executive Officer, Treasurer, CFO, Principal Accounting Officer, Secretary, Treasurer and as sole Director. 8.01 Effective October 19, 2012, the Company has moved its executive offices to 5348 Vegas Drive, #239, Las Vegas, Nevada 89108. | f8k.htm |
| 2012-04-27 | 8-K/A | 2012-04-16 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On April 16, 2012, Entertainment Art, Inc., (the “Company”), provided notice to its independent registered public accounting firm, Wolinetz, Lafazan & Company, CPA’s, P.C. (“WLC”), that the Company dismissed WLC, effective as of that date citing business reasons. | eert_8ka.htm |
| 2012-04-20 | 8-K | 2012-04-16 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On April 16, 2012, Entertainment Art, Inc., (the “Company”), provided notice to its independent registered public accounting firm, Wolinetz, Lafazan & Company, CPA’s, P.C. (“WLC”), that the Company decided to change accounting firms, effective as of that date citing business reasons. | eert_8k.htm |
| 2011-10-12 | 8-K | 2011-10-10 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (b) On October 10, 2011, Mr. Joseph Koegel resigned as President, Chief Executive Officer, and as a member of the board of directors of Entertainment Art, Inc. (the "Company"). | entertainment_8k.htm |
| 2009-05-04 | 8-K | 2009-05-01 | 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.01 On May 1, 2009, Joseph Koegel, Ian Beiss and David Lubin, the principal shareholders of Entertainment Art, Inc. (the “Company”), entered into a Stock Purchase Agreement which provided for the sale of 1,200,000 shares of common stock of the Company (the “Purchased Shares”) owned by the three principals to Medford Financial Ltd (the “Purchaser”). 5.02 Effective as of May 1, 2009, in connection with the disposition of the Purchase Shares, Ian Beiss resigned from all his positions as an officer and director of the Company. | entart_8k5-4.htm |